Funds › Alphabet Inc.

Alphabet Inc.

Ask your AI

13F for Q3 2026, filed Nov 6, 2026. 29 positions worth $88.3B.

Latest report

Q3 2026

filed Nov 6, 2026

Reported value

$88.3B

−$10.7B (10.8%) vs Q2 2026

Positions

28 in Q2 2026

Top 10 share

99.5%

of reported value

Checked

Clean

prices match other managers' reports

Ask your AI about this

Connect Claude, ChatGPT, Gemini or Grok (Microsoft 365 Copilot coming soon) to 13F.ai and ask in plain English. Copy a question to get started:

Using 13F.ai, what are the biggest new, added, trimmed and exited positions of Alphabet Inc. in the latest 13F quarter?
Using 13F.ai, how has Alphabet Inc.'s portfolio concentration changed over the last four quarters?
Using 13F.ai, which of Alphabet Inc.'s top holdings have also been bought by insiders recently?

Connect your AI · Plans and the 7-day free trial (card required)

Holdings, Q3 2026

Largest first. Common shares only.

Latest 13F holdings
#						Filing
1	SPCX Space Exploration Technologies Corp.	555.04M	$83.7B	94.8%	+0.7%	13F ↗
2	CME CME Group Inc.	3.48M	$912.7M	1.0%	Unchanged	13F ↗
3	PL Planet Labs PBC	35.25M	$577.7M	0.7%	Unchanged	13F ↗
4	ARM Arm Holdings plc	1.96M	$568.0M	0.6%	Unchanged	13F ↗
5	RVMD Revolution Medicines, Inc.	2.67M	$548.8M	0.6%	-9.3%	13F ↗
6	QCOM QUALCOMM Incorporated	2.98M	$547.9M	0.6%	New	13F ↗
7	ASTS AST SpaceMobile, Inc.	8.94M	$526.4M	0.6%	Unchanged	13F ↗
8	FRSH Freshworks Inc.	14.34M	$183.4M	0.2%	-11.5%	13F ↗
9	PBLS Parabilis Medicines, Inc.	4.92M	$158.9M	0.2%	Unchanged	13F ↗
10	TEM Tempus AI, Inc.	1.55M	$127.0M	0.1%	Unchanged	13F ↗
11	PATH UiPath, Inc.	7.03M	$90.3M	0.1%	Unchanged	13F ↗
12	LIME Neutron Holdings, Inc.	1.90M	$53.5M	0.1%	New	13F ↗
13	PRME Prime Medicine, Inc.	16.56M	$50.7M	0.1%	Unchanged	13F ↗
14	PAYP PayPay Corporation · ADR	3.13M	$49.1M	0.1%	Unchanged	13F ↗
15	MAZE Maze Therapeutics, Inc.	1.39M	$37.7M	<0.1%	Unchanged	13F ↗
16	FRNM Freenome, Inc.	2.02M	$31.8M	<0.1%	New	13F ↗
17	RLAY Relay Therapeutics, Inc.	1.41M	$25.5M	<0.1%	Unchanged	13F ↗
18	FRVO Fervo Energy Company	1.76M	$23.9M	<0.1%	Unchanged	13F ↗
19	LIFE Ethos Technologies Inc.	571,907	$19.2M	<0.1%	-84.2%	13F ↗
20	OBX Obsidian Therapeutics, Inc.	1.22M	$16.8M	<0.1%	New	13F ↗
21	OSCR Oscar Health, Inc.	481,988	$14.9M	<0.1%	Unchanged	13F ↗
22	BBOT BridgeBio Oncology Therapeutics, Inc.	2.82M	$11.6M	<0.1%	Unchanged	13F ↗
23	SANA Sana Biotechnology, Inc.	2.81M	$8.2M	<0.1%	Unchanged	13F ↗
24	BEAM Beam Therapeutics Inc.	321,604	$7.9M	<0.1%	Unchanged	13F ↗
25	VERA Vera Therapeutics, Inc.	241,264	$7.8M	<0.1%	Unchanged	13F ↗
26	FIG Figma, Inc.	215,582	$4.5M	<0.1%	Unchanged	13F ↗
27	GLUE Monte Rosa Therapeutics, Inc.	372,474	$4.4M	<0.1%	Unchanged	13F ↗
28	LYEL Lyell Immunopharma, Inc.	293,256	$2.9M	<0.1%	Unchanged	13F ↗
29	HYPR Hyperfine, Inc.	898,720	$728.0K	<0.1%	Unchanged	13F ↗

Show all 29 positionsShow only the first 15

Changes since Q2 2026

4 new, 1 added to, 3 trimmed, 3 exited, 21 unchanged. By estimated dollars.

New positions (4)

New positions

QCOM QUALCOMM Incorporated	2.98M	New	$547.9M
LIME Neutron Holdings, Inc.	1.90M	New	$53.5M
FRNM Freenome, Inc.	2.02M	New	$31.8M
OBX Obsidian Therapeutics, Inc.	1.22M	New	$16.8M

Added to (1)

Added to
Position	Shares	Change	Est. dollars
SPCX Space Exploration Technologies Corp.	555.04M	+0.7%	$581.4M

Trimmed (3)

Trimmed

LIFE Ethos Technologies Inc.	571,907	-84.2%	-$102.4M
RVMD Revolution Medicines, Inc.	2.67M	-9.3%	-$56.0M
FRSH Freshworks Inc.	14.34M	-11.5%	-$23.9M

Exited (3)

Exited

GTLB GitLab Inc.	2.72M	Exited	-$83.2M
SPRO Spero Therapeutics, Inc.	889,979	Exited	-$2.0M
AUTL Autolus Therapeutics plc	698,262	Exited	-$1.1M

The 10 largest of each, by estimated dollars: shares changed times the later report's price. Index tracking, splits and mergers move positions too.

Compare two quarters

Pick any two quarters: what is new, added to, trimmed or exited. Premium plan.

Reported value by quarter

Value and number of positions at the end of each quarter.

Reported value by quarter

Q3 2026	$88.3B	-10.8%	29
Q2 2026	$99.1B	+2367.4%	28
Q1 2026	$4.0B	+55.7%	26
Q4 2025	$2.6B	+7.1%	29
Q3 2025	$2.4B	+12.8%	37
Q2 2025	$2.1B	+35.4%	36
Q1 2025	$1.6B	-8.2%	40
Q4 2024	$1.7B	-6.8%	40
Q3 2024	$1.8B	-6.7%	42
Q2 2024	$2.0B	-21.5%	42
Q1 2024	$2.5B	+16.6%	43
Q4 2023	$2.2B	+38.5%	44
Q3 2023	$1.6B	-16.3%	45
Q2 2023	$1.9B		47
Q1 2023	$1.8B		49
Q4 2022	$1.7B		51
Q3 2022	$2.0B		49
Q2 2022	$1.8B		55
Q1 2022	$3.1B		60
Q4 2021	$4.1B		58
Q3 2021	$4.2B		43
Q2 2021	$4.9B		36
Q1 2021	$2.5B		32
Q4 2020	$2.1B		31
Q3 2020	$2.1B		24
Q2 2020	$2.2B		24
Q1 2020	$1.5B		25
Q4 2019	$1.7B		24
Q3 2019	$3.3B		24
Q2 2019	$5.3B		22
Q1 2019	$1.9B		17
Q4 2018	$845.8M		17
Q3 2018	$1.0B		17
Q2 2018	$1.2B		17
Q1 2018	$614.8M		11
Q4 2017	$368.6M		8
Q3 2017	$344.0M		4
Q2 2017	$347.4M		4
Q1 2017	$316.8M		3
Q4 2016	$292.8M		2
Q3 2016	$275.2M		2
Q2 2016	$209.8M		3
Q1 2016	$242.9M		5
Q4 2015	$326.8M		5
Q3 2015	$416.1M		5
Q2 2015	$482.2M		5
Q1 2015	$601.0M		5
Q4 2014	$659.6M		6
Q3 2014	$304.5M		4
Q2 2014	$383.2M		4
Q1 2014	$381.1M		3
Q4 2013	$365.1M		4

Reported value is the fund's own total for its long positions in US-listed securities on the last day of each quarter, from Q4 2013 to Q3 2026. It does not include short positions or cash, and a report arrives up to 45 days after the quarter ends.

A change in value reflects price moves as well as buying and selling. Positions count every line of the report, options and bonds included.

Reported value by quarter

Value and number of positions at the end of each quarter.

Loading…

Largest positions in earlier quarters

Pick a quarter to see what the fund's biggest positions were then.

Older quarters (39)

Q2 2026 (period ending Jun 30, 2026)

Largest positions, Q2 2026
#
1	SPCX Space Exploration Technologies Corp.	551.19M	$94.2B	95.0%
2	PL Planet Labs PBC	35.25M	$1.2B	1.2%
3	ASTS AST SpaceMobile, Inc.	8.94M	$794.7M	0.8%
4	CME CME Group Inc.	3.48M	$769.4M	0.8%
5	ARM Arm Holdings plc	1.96M	$695.2M	0.7%
6	RVMD Revolution Medicines, Inc.	2.95M	$551.8M	0.6%
7	FRSH Freshworks Inc.	16.21M	$164.0M	0.2%
8	PBLS Parabilis Medicines, Inc.	4.92M	$134.6M	0.1%
9	TEM Tempus AI, Inc.	1.55M	$89.9M	0.1%
10	GTLB GitLab Inc.	2.72M	$83.2M	0.1%
11	PATH UiPath, Inc.	7.03M	$76.5M	0.1%
12	LIFE Ethos Technologies Inc.	3.62M	$65.7M	0.1%
13	PRME Prime Medicine, Inc.	16.56M	$61.1M	0.1%
14	FRVO Fervo Energy Company	1.76M	$51.5M	0.1%
15	PAYP PayPay Corporation · ADR	3.13M	$44.8M	<0.1%
16	MAZE	1.39M	$41.4M	<0.1%
17		1.41M	$26.4M	<0.1%
18		2.82M	$21.5M	<0.1%
19		481,988	$13.7M	<0.1%
20		321,604	$11.0M	<0.1%
21		241,264	$10.4M	<0.1%
22		2.81M	$9.8M	<0.1%
23		372,474	$9.0M	<0.1%
24		293,256	$4.1M	<0.1%
25		215,582	$3.9M	<0.1%

The 25 largest positions by value in the fund's report for Q2 2026, common shares only. For earlier quarters we list the 10 largest positions of each fund, and the 25 largest for funds that report $10 billion or more. Values are the fund's own figures at the end of that quarter.

Largest positions in earlier quarters

Pick a quarter to see what the fund's biggest positions were then.

Loading…

Ten largest positions

By value, Q3 2026.

Filings

13F filings
						Filing
Q3 2026	Nov 6, 2026	13F-HR	29	$88.3B	Current	SEC ↗
Q2 2026	Aug 7, 2026	13F-HR	28	$99.1B	Current	SEC ↗
Q1 2026	May 8, 2026	13F-HR	26	$4.0B	Current	SEC ↗
Q4 2025	Feb 13, 2026	13F-HR	29	$2.6B	Current	SEC ↗
Q3 2025	Nov 7, 2025	13F-HR	37	$2.4B	Current	SEC ↗
Q2 2025	Aug 1, 2025	13F-HR	36	$2.1B	Current	SEC ↗
Q1 2025	May 2, 2025	13F-HR	40	$1.6B	Current	SEC ↗

Most recent first, up to 80. An amendment can replace a report or add holdings to it. All 13F filings

Information, not investment advice. Values are the fund's own figures at quarter end; a report can be up to 45 days old when filed. Disclaimer